Tectonic Therapeutic Inc stock is traded at $20.73, with a volume of 268,829. It is down -1.47% in the last 24 hours and down -5.02% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Previous Close:
$21.04
Open:
$20.70
24h Volume:
268,829
Relative Volume:
1.50
Market Cap:
$405.26M
Revenue:
-
Net Income/Loss:
-$83.49M
P/E Ratio:
-
EPS:
-$4.46
Net Cash Flow:
-$60.29M
1W Performance:
-1.94%
1M Performance:
-5.02%
6M Performance:
-28.12%
1Y Performance:
+14.78%
1-Day Range:
$20.41$21.57
1-Week Range:
$19.76$21.57
52-Week Range:
$16.77$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic IncSector
HealthcareIndustry
BiotechnologyPhone
(339) 666-3320Address
490 ARSENAL WAY, WATERTOWN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS